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Abstract
In skin, connective tissue growth factor (CTGF/CCN2) is induced during tissue repair. However,
what the exact cell types are that express CTGF in normal and wounded skin remain controversial.
In this report, we use transgenic knock-in mice in which the Pacific jellyfish Aequorea victoria
enhanced green fluorescent protein (E-GFP) gene has been inserted between the endogenous
CTGF promoter and gene. Unwounded (day 0) and wounded (days 3 and 7) skin was examined for
GFP to detect cells in which the CTGF promoter was active, α-smooth muscle actin (α-SMA) to
detect myofibroblasts, and NG2 expression to detect pericytes. In unwounded mice, CTGF
expression was absent in epidermis and was present in a few cells in the dermis. Upon wounding,
CTGF expression was induced in the dermis. Double immunolabeling revealed that CTGF-
expressing cells also expressed α-SMA, indicating the CTGF was expressed in myofibroblasts. A
subset (~30%) of myofibroblasts were also NG2 positive, indicating that pericytes significantly
contributed to the number of myofibroblasts in the wound. Pericytes also expressed CTGF.
Collectively, these results indicate that CTGF expression in skin correlates with myofibroblast
induction, and that CTGF-expressing pericytes are significant contributors to myofibroblast activity
during cutaneous tissue repair.
Background
Tissue repair involves the reconstitution of connective tis-
sue. During this process, fibroblasts migrate into the
wound where they produce and subsequently remodel
extracellular matrix (ECM), resulting in wound closure.
These events are mediated by a specialized form of fibrob-
lasts, termed myofibroblasts [1]. Persistence of the myofi-
broblast is a hallmark of fibrotic lesions [2,3]. However,
the origin of myofibroblasts during tissue repair remains
controversial [4]. For example, it is uncertain to what
extent activated myofibroblasts derive from local recruit-
ment of fibroblasts or from pericytes surrounding blood
vessels [5].
Connective tissue growth factor (CTGF/CCN2), a member
of the CCN family of proteins [6], acts through integrins
and heparan sulfate-containing proteoglycans (HSPGs),
which are the bona fide CTGF receptors, to directly induce
and modify adhesive signaling both independently and in
response to growth factors and extracellular matrix [7-10].
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CTGF is expressed in mesenchymal cells during develop-
ment and wound healing [11,12] and is overexpressed in
fibrotic diseases [13]. Studies on CTGF gene regulation
have been performed using a variety of cell culture sys-
tems, including fibroblasts, and mesangial and cancer
cells [13-17]. However, what the actual cell types that
express CTGF in vivo are remains somewhat controversial.
For example, studies employing various antibodies
directed toward CTGF have been used to examine CTGF
protein expression in development, with widely divergent
results (see [18,19]); one study used Western blot analysis
of tissue extracted from wound chambers introduced sub-
cutaneously to show that CTGF is induced in tissue repair,
but is absent normally [11]. Conversely, another study
used in situ hybridization to show that CTGF mRNA was
constitutively expressed in normal human skin [20].
These problems may have arisen due to possible difficul-
ties regarding either the sensitivity of the detection meth-
ods used or cross-reactivity among related family
members. Moreover, the CCN family consists of secreted
proteins, making the identification of individual cell types
expressing CTGF difficult. Careful in vivo analysis of cells
expressing CTGF has not been performed.
The green fluorescent protein (GFP) reporter has been
used in vivo to detect the specific cells in which gene pro-
moters are active [21,22]. Such a reporter is particularly
useful to avoid possible issues regarding sensitivity of in
situ hybridization to particular mRNAs, especially regard-
ing possible cross-hybridization among members of
related protein families, and when there are possible
issues regarding antibody sensitivities. In this study, we
report the findings from our investigation of knock-in
mice where enhanced GFP (E-GFP) has been inserted
between the endogenous CTGF promoter and gene. These
mice were derived from a previously reported screen in
which bacterial artificial chromosomes (BACs) were
inserted into the genome [23]. Mice were subjected to the
dermal punch model of tissue repair, and the expression
of CTGF was detected using an anti-GFP antibody. More-
over, activated myofibroblasts and pericytes were detected
using appropriate markers. Our data provide the first care-
ful analysis of the cell types that express CTGF in skin.
Moreover, our data provide new insights into the origin of
the activated fibroblasts during normal tissue repair.
Results
CTGF promoter activity is induced post-wounding in 
myofibroblasts
To date, the cell types that express CTGF in skin pre- and
post-wounding have not been known. To address this out-
standing issue, we used transgenic mice in which the E-
GFP gene has been inserted between the endogenous
CTGF promoter and gene. As E-GFP is not secreted, the
precise cells expressing it can be detected using an anti-
GFP antibody. An anti-GFP antibody was used, as
opposed to direct examination of E-GFP, to avoid possible
issues due to autofluorescence. When unwounded skin
was examined, GFP expression was not detected in the
epidermis (Figure 1, day 0). A few GFP-positive cells were
detected in the hair follicle and in the dermis; however,
GFP-positive cells were essentially absent in unwounded
skin (Figure 1, day 0). By 3 days post-wounding, GFP-pos-
itive cells appeared in the dermis, but were absent from
the epithelia (Figure 1, day 3). By 7 days post-wounding,
abundant GFP-positive cells were present in the newly-
synthesized tissue (Figure 1, day 7). Similar patterns of
expression were observed when tissue sections were
stained with anti-α-smooth muscle actin (SMA) antibody
to detect activated fibroblasts (that is, the presence of
myofibroblasts) (Figure 2). Moreover, cells in which the
CTGF promoter was active were also α-SMA positive (Fig-
ure 3). Collectively, these data indicate that CTGF pro-
moter activity is minimal in unwounded skin and is
induced post-wounding in myofibroblasts.
Approximately a third of the myofibroblasts in the day 7 
wound are pericytes
A large body of evidence indicates that vascular pericytes
may be a major source of activated myofibroblasts during
normal wound healing and fibrosis [4,5]. To investigate
(a) the precise contribution of pericytes to the activated
fibroblasts present in wounded tissue, and (b) if the CTGF
promoter was active in pericytes, we first performed dou-
ble immunolabeling of tissue sections with anti-NG2
antibody, to detect pericytes, and anti-α-SMA antibody, to
address the relative contribution of pericytes to the acti-
vated myofibroblasts in the wound. At day 3 post-wound-
ing, 70–80% of the cells in the wound, whether at the
edge or in the center, were myofibroblasts, as detected by
anti-α-SMA antibody (Figure 4a). Of these, ~30–40%
stained positive with an anti-NG2 antibody (Figure 3a).
At day 7 post-wounding, ~90% of the cells were myofi-
broblasts (Figure 4b). At this timepoint, ~40% were NG2
positive; overall approximately a third of the myofibrob-
lasts were also pericytes (Figure 4b).
The CTGF promoter is active in pericytes
To investigate whether the CTGF promoter was active in
pericytes, we stained sections with anti-GFP and anti-NG2
antibodies. These data revealed that, at 3 days post-
wounding, ~60% of the cells at the center of the wound
and ~80% of the cells at the wound edge were GFP posi-
tive while ~20% and ~40%, respectively, of the cells were
both GFP and NG2 positive (Figure 5a). By day 7 post-
wounding ~80% of the cells at the center and wound edge
were GFP positive, whereas ~30% of the cells at the center
of the wound and ~45% at the wound edge were both
GFP and NG2 positive (Figure 5b). These results indicate
that the CTGF promoter is active in pericytes. Collectively,Fibrogenesis & Tissue Repair 2008, 1:3 http://www.fibrogenesis.com/content/1/1/3
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Connective tissue growth factor (CTGF) promoter activity in skin pre- and post-wounding Figure 1
Connective tissue growth factor (CTGF) promoter activity in skin pre- and post-wounding. Skin of CTGF/
enhanced green fluorescent protein (E-GFP) hemizygous mice (pre-wounding, day 0, or post-wounding, day 3 or day 7) was 
fixed, sectioned, and stained with 4',6-diamidino-2-phenylindole (DAPI) to detect nuclei or anti-GFP antibody to detect cells in 
which the CTGF promoter was active (lefthand panels, 10 × magnification of dermal tissue; righthand panels, 40 × magnification 
of dermal tissue). Semiquantitative analysis of GFP expression was performed as described in Methods. Note that CTGF pro-
moter activity, as determined by GFP-positive cells, was absent in the epidermis (day 0); however, a small number of dermal 
cells were positive for GFP expression. Post-wounding, the CTGF promoter was active in granulation tissue. *, significant 
induction compared to day 0 unwounded skin. Representative data from four wounds from four separate animals per time-
point is shown.Fibrogenesis & Tissue Repair 2008, 1:3 http://www.fibrogenesis.com/content/1/1/3
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The presence of α-smooth muscle actin (SMA) expression myofibroblast pre- and post-wounding Figure 2
The presence of α-smooth muscle actin (SMA) expression myofibroblast pre- and post-wounding. Skin of con-
nective tissue growth factor/enhanced green fluorescent protein (CTGF/E-GFP) hemizygous mice (pre-wounding, day 0, or 
post-wounding, day 3 or day 7) was fixed, sectioned, and stained with 4',6-diamidino-2-phenylindole (DAPI) to detect nuclei or 
anti-α-SMA antibody to detect myofibroblasts (lefthand panels, 10 × magnification of dermal tissue; righthand panels, 40 × mag-
nification of dermal tissue). Quantitiation of myofibroblasts was performed as described in Methods. Note that α-SMA expres-
sion was absent in the epidermis (day 0); however, a small number of dermal cells were positive for α-SMA expression. Post-
wounding, myofibroblasts appeared within granulation tissue. *, significant induction compared to day 0 unwounded skin. Rep-
resentative data from four wounds from four separate animals per timepoint is shown.Fibrogenesis & Tissue Repair 2008, 1:3 http://www.fibrogenesis.com/content/1/1/3
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our data strongly indicate that CTGF expression is an
excellent marker for activated fibroblasts participating in
wound healing in vivo.
Discussion
The CCN family comprises six secreted proteins grouped
together on the basis of a similar predicted modular sec-
ondary structure [6]. CTGF is induced during tissue repair,
and elevated, constitutive CTGF expression is a hallmark
of fibrosis [11,13]. Although many studies in cell culture
have shown that CTGF expression can be induced in
fibroblasts, e.g. by transforming growth factor (TGF)β and
endothelin-1 [14,24], CTGF can be induced in other cell
types as well [6]. Based on the evidence in the literature, it
is unclear whether the CTGF promoter is active in normal
skin and whether it is induced in fibroblasts or epithelia
post-wounding [11,20]. In this report, we show that CTGF
promoter activity is essentially absent in normal skin, but
is induced post-wounding in myofibroblasts. Although
pericytes are believed to contribute to the total number of
myofibroblasts in wound tissue [4,5], for the first time we
show that pericytes comprise about a third of the number
of activated wound fibroblasts. Consistent with the
notion that CTGF is expressed in activated fibroblasts, the
CTGF promoter was active in pericytes. Our data support
the hypothesis that CTGF promoter activity is a good
marker of fibroblast activation and fibrogenesis in vivo,
and that CTGF may be a key selective contributor to fibro-
genesis and tissue repair in vivo [25]. Identification of the
specific cell types that contribute to recruited CTGF- and
The connective tissue growth factor (CTGF) promoter is active in myofibroblasts Figure 3
The connective tissue growth factor (CTGF) promoter is active in myofibroblasts. Skin of CTGF/enhanced green 
fluorescent protein (E-GFP) hemizygous mice (post-wounding, day 3) was fixed, sectioned, and stained with 4',6-diamidino-2-
phenylindole (DAPI) to detect nuclei, anti-α-smooth muscle actin (SMA) antibody to detect myofibroblasts, and anti-GFP anti-
body to detect CTGF promoter activity (40 × magnification of dermal tissue). The percentage of fibroblasts within the wound 
that were α-SMA positive, GFP positive, and both GFP and α-SMA positive was calculated as described in Methods. Note that 
~75% of the cells in the wound area were myofibroblasts that expressed GFP. Representative data from four wounds from 
four separate animals per timepoint is shown.Fibrogenesis & Tissue Repair 2008, 1:3 http://www.fibrogenesis.com/content/1/1/3
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A subset of the myofibroblasts within wound tissue are pericytes Figure 4
A subset of the myofibroblasts within wound tissue are pericytes. Skin of connective tissue growth factor/enhanced 
green fluorescent protein (CTGF/E-GFP) hemizygous mice post-wounding (a) day 3 and (b) day 7 was fixed, sectioned, and 
stained with 4',6-diamidino-2-phenylindole (DAPI) to detect nuclei, anti-α-smooth muscle actin (SMA) antibody to detect 
myofibroblasts, and anti-NG2 antibody to detect pericytes (10 × magnification of dermal tissue). The center of the wound and 
wound edges were examined and the percentage of fibroblasts within the wound that were α-SMA positive, NG2 positive, and 
both NG2 and α-SMA positive was calculated as described in Methods. At day 3, note that ~20% of the cells in the wound area 
were both α-SMA and NG2 positive whereas ~40% of the cells at the wound edges were α-SMA and NG2 positive, indicating 
that pericytes are recruited to the wound from surrounding tissue. At day 7, note that essentially all cells in the wound area 
are myofibroblasts. Approximately 30% of the cells in the center of the wound are myofibroblasts of pericyte origin. In the 
wound edge, ~40% of the cells are myofibroblasts of pericyte origin. Representative data from four wounds from four separate 
animals per timepoint is shown.Fibrogenesis & Tissue Repair 2008, 1:3 http://www.fibrogenesis.com/content/1/1/3
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The connective tissue growth factor (CTGF) promoter is active in pericytes Figure 5
The connective tissue growth factor (CTGF) promoter is active in pericytes. Skin of CTGF/enhanced green fluores-
cent protein (E-GFP) hemizygous mice post-wounding (a) day 3 and (b) day 7 was fixed, sectioned, and stained with 4',6-dia-
midino-2-phenylindole (DAPI) to detect nuclei, anti-GFP antibody to detect cells in which the CTGF promoter is active, and 
anti-NG2 antibody to detect pericytes (10 × magnification of dermal tissue). The center of the wound and wound edges were 
examined and the percentage of fibroblasts within the wound that were GFP positive, NG2 positive, and both NG2 and GFP 
positive was calculated as described in Methods. At day 3 and 7, note that essentially all pericytes were GFP positive, and hence 
showed CTGF promoter activity. Representative data from four wounds from four separate animals per timepoint is shown.Fibrogenesis & Tissue Repair 2008, 1:3 http://www.fibrogenesis.com/content/1/1/3
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α-SMA-expressing myofibroblasts in tissue repair is essen-
tial for delineating new mechanisms underlying
(myo)fibroblast biology during tissue repair and fibrosis.
Methods
Generation of E-GFP tagged mice
Mice were derived from a screen initially conduced by
Gong and colleagues [23]. Modified BACs containing
inserted E-GFP upstream of targeted genes were injected
into pronuclei of FVB/N fertilized mouse oocytes.
Hemizygous progeny (STOCK Tg(Ctgf-EGFP)156Gsat;
Mutant Mouse Regional Resource Centers (MMRRC
[26])) were mated to Swiss Webster mice each generation
thereafter. To detect the transgene, mice were subjected to
the polymerase chain reaction (PCR) with CACGTAG-
GAGGATGGCGCAGGGCTAG and TAGCGGCTGAAG-
CACTGCA as primers, using a standard protocol as
described on the MMMRRC website [27].
Wound surgery
Mice (6 weeks old) containing one copy of the CTGF/E-
GFP allele were anesthetized by intraperitoneal injection
of 90 μg ketamine plus 10 μg xylazine/g, and their back
skin was shaved, depilated with commercially available
hair removal cream (Nair; Church and Dwight, Princeton,
NJ, USA) and cleaned with alcohol. Using a sterile 4-mm
biopsy punch, four bilateral full-thickness skin wounds
were created on the dorsorostral back skin. Wounds were
separated by a minimum of 6 mm of uninjured skin. Mice
were killed by CO2 euthanasia after 0, 3 and 7 days post-
wounding and wound tissue biopsies were collected for
immunoflourescence.
Immunofluorescence
Wound tissue sections (0.5 μm) were cut using a micro-
tome (Leica, Richmond Hill, ON, Canada) and collected
on Superfrost Plus slides (Fisher Scientific, Ottawa, ON,
Canada). Sections were then de-waxed in xylene and rehy-
drated by successive immersion in descending concentra-
tions of alcohol. Sections were then subjected to single or
double immunofluorescence. Briefly, tissue sections were
incubated with mouse serum for 30 min and washed with
phosphate-buffered saline (PBS). Sections were then incu-
bated with primary antibodies for 1 h at room tempera-
ture under humidified conditions. Primary antibodies
used alone (single immunofluorescence) or in combina-
tion (double immunofluorescence) were: rabbit anti-
green fluorescent protein (anti-GFP; 1:100 dilution, Invit-
rogen, Burlington, ON, Canada), mouse anti-NG2 (peri-
cyte marker, 1:100 dilution, Chemicon, Millipore,
Billerica, MA, USA), mouse anti-alpha-smooth muscle
actin (α-SMA, 1:100 dilution, Sigma, St Louis, MO, USA).
Double immunofluorescence for α-SMA and NG2 was
performed using rabbit polyclonal antibody for α-SMA
(Abcam, Cambrodge, MA, USA) and mouse antibody for
NG2. Both rabbit and mouse antibodies for α-SMA
showed identical staining of cells and tissues in our sys-
tem. After primary antibody incubation, sections were
then washed with PBS and incubated with appropriate
fluorescent secondary antibodies (Jackson Immunore-
search, West Grove, PA, USA) for 1 h at room temperature.
Sections were then washed with PBS and mounted using
4',6-diamidino-2-phenylindole (DAPI) and photo-
graphed using a Zeiss fluorescence microscope and North-
ern Eclipse software (Empix, Missassagua, ON, Canada).
Six independent fields were examined per data point.
The tissue expression of GFP/CTGF and α-SMA on days 0,
3 and 7 post-wounding was graded on a scale of 0–3 by
three blinded observers; 0 signifies no staining, 1 signifies
very little staining, 2 signifies moderate staining, 3 signi-
fies extensive staining.
Sections undergoing double immunofluorescence were
photographed at 10 × (for whole tissue section) and 60 ×
(for cells) magnifications. To detect number of α-SMA,
GFP/CTGF or NG2 positive cells in and around wound
area, two planes were chosen: (a) cells in the centre of the
wound, and (b) infiltrating cells at wound edges. At each
plane, the total number of cells/mm2 were counted. Sub-
sequently, the number of α-SMA, GFP/CTGF and NG2
positive cells/mm2 were counted and expressed as per-
centage positive cells at each plane.
Statistical analysis
Statistical analysis was performed using the Student t test.
Results are expressed as the mean ± standard error of the
mean (SEM). A p value < 0.05 was considered statistically
significant.
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